Lilly Urges Biden Administration to Halt Drug Price Negotiations

In a surprising turn of events, Eli Lilly, a major player in the pharmaceutical industry, has formally requested that the Biden administration place a pause on the ongoing negotiations regarding drug pricing. This request comes amidst growing concerns and efforts from various pharmaceutical firms regarding the impact of recent legislative changes on their operations and profitability.

Continue reading